Adjuvant Capecitabine and Oxaliplatin for Gastric Cancer: Results of the Phase 3 CLASSIC Trial - ONA
Links shared publicly online about this topic.
- 236total visits
Adjuvant Capecitabine and Oxaliplatin for Gastric Cancer: Results of the Phase 3 CLASSIC Trial - ONA
Adjuvant capecitabine and oxaliplatin (XELOX) demonstrated superior efficacy when compared with observation alone following D2 gastrectomy for gastric cancer, according to study results presented at the American Society of Clinical Oncology’s 2011 Annual Meeting.
View full resource at oncologynurseadvisor.com
Tags: Cancer, Cancer Medication, Colorectal Cancer Medication, Stomach Cancer, Eloxatin, Eloxatine, Xeloda
Most Recently Shared on June 7, 2011 at 4:12 pm By:
Adjuvant Capecitabine and Oxaliplatin for Gastric Cancer: Results of the Phase 3 CLASSIC Trial http://goo.gl/fb/0oUKs
Advertisement
